[Federal Register Volume 84, Number 214 (Tuesday, November 5, 2019)]
[Notices]
[Pages 59645-59646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24105]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-530]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of schedule I and II controlled substances.
    The companies listed below applied to be registered as an importers 
of various basic classes of schedule I and II controlled substances. 
Information on previously published notices is listed in the table 
below. No comments or objections were submitted and no requests for a 
hearing were submitted for these notices.

------------------------------------------------------------------------
          Companies                FR docket             Published
------------------------------------------------------------------------
Catalent Pharma Solutions,    84 FR 36945         July 30, 2019.
 LLC.
Research Triangle Institute.  84 FR 36941         July 30, 2019.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable various basic classes of schedule I and II 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each of the 
company's maintenance of effective controls against diversion by 
inspecting and testing each company's physical security systems, 
verifying

[[Page 59646]]

each company's compliance with state and local laws, and reviewing each 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I and II controlled substances to the above 
listed companies.

    Dated: October 22, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-24105 Filed 11-4-19; 8:45 am]
BILLING CODE 4410-09-P